Press Releases

The GOLDEN-3 and GOLDEN-4 Phase 3 trials evaluating SUN-101/eFlow® in people with moderate-to-very severe COPD met their primary endpoint with a statistically significant change from baseline in trough FEV1 at Week 12. World pharma today/Press releases...

Expansion to add more than 100 full time jobs to local Waco and Central Texas economies -- Will add 322,000 square feet of manufacturing space, nearly doubling current footprint. Will increase Waco facility production capacity by...

Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from three Mallinckrodt-sponsored retrospective analyses providing health economic insights for the use of H.P. Acthar Gel (repository corticotropin injection; RCI) in three distinct patient populations:...

Australia’s largest and most successful biotechnology company, CSL, will officially celebrate 100 years of operation on 25th April 2016. World pharma today/Press releases /-Originally named the ‘Commonwealth Serum Laboratories’, CSL was established in 1916 by the...

AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. The initiative includes new collaborations with Human...

CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC. The four-in-one event will take place at the Istanbul Congress Center (ICC).   Turkey, from...

Novo Nordisk announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. The expansions will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines. ...